About
Technology
Issues
FAQ
Links
Official Page
ADAMTS5 Is a Biomarker for Prediction of Response to Infliximab in Patients with Rheumatoid Arthritis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.